Identification of a novel anti‑heat shock cognate 71 kDa protein antibody in patients with Kawasaki disease

Zhou,Yabin; Cui,Jiawen; Hu,Huimin; Wen,Yongqiang; Du,Zhongdong; Du,Hongwu

doi:10.3892/mmr.2020.10973

Identification of a novel anti‑heat shock cognate 71 kDa protein antibody in patients with Kawasaki disease

Authors:
- Yabin Zhou
- Jiawen Cui
- Huimin Hu
- Yongqiang Wen
- Zhongdong Du
- Hongwu Du
View Affiliations

Affiliations: School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, P.R. China, Department of Pediatrics, Beijing Children's Hospital, Capital Medical University, Beijing 100045, P.R. China
Published online on: February 4, 2020 https://doi.org/10.3892/mmr.2020.10973
Pages: 1771-1778
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kawasaki disease (KD) is an idiopathic form of acute systemic vasculitis, which clinically mimics febrile diseases. Although it has been hypothesized that immune system malfunction is associated with KD, its etiology remains unclear. The aim of the present study was to identify a KD‑associated antibody. Immunoproteomic methods were used to identify KD‑associated antigens that could be recognized in the sera of patients with KD. HeLa cells were used as an antigen source and KD sera were used as probe antibodies to determine the binding of the antibodies using an indirect immunofluorescence assay. Western blotting was performed to identify KD‑associated antigens in HeLa whole cell lysates. Eight out of 12 serum samples obtained from patients with KD demonstrated immunoreactive bands at ~70 kDa, which was later determined to be heat shock cognate 71 kDa protein (HSP7C) by mass spectrometry. The diagnostic value of serum anti‑HSP7C antibodies for KD was assessed using ELISA. Using a cut‑off value of 0.267, anti‑HSP7C antibodies were observed to be present in the sera of 60.00% (30/50) of patients with KD, in 21.05% (8/38) of non‑KD febrile controls, and in 5.26% (2/38) of healthy controls. High serum levels of anti‑HSP7C antibodies were detected in the peripheral circulation of patients with KD. To the best of our knowledge, the present study is the first to observe the high expression levels of anti‑HSP7C antibodies in patients with KD. Therefore, anti‑HSP7C antibodies may be used as a diagnostic marker to detect KD.

View Figures

View References

1	Kawasaki T: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 16:178–222. 1967.(In Japanese). PubMed/NCBI
2	Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, Takahashi M, Bierman FZ, Karchmer AW, Wilson W, et al: Diagnosis and therapy of Kawasaki disease in children. Circulation. 87:1776–1780. 1993. View Article : Google Scholar : PubMed/NCBI
3	Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G and Yamakawa R: Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 94:1379–1385. 1996. View Article : Google Scholar : PubMed/NCBI
4	Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J and Yeung RS: Infections and Kawasaki disease: Implications for coronary artery outcome. Pediatrics. 116:e760–e766. 2005. View Article : Google Scholar : PubMed/NCBI
5	Takahashi K, Oharaseki T and Yokouchi Y: Pathogenesis of Kawasaki disease. Clin Exp Immunol. 164 (Suppl 1):S20–S22. 2011. View Article : Google Scholar
6	Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, et al: Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, council on cardiovascular disease in the Young, American Heart Association. Pediatrics. 114:1708–1733. 2004. View Article : Google Scholar : PubMed/NCBI
7	Onouchi Y: Genetics of Kawasaki disease: What we know and don't know. Circ J. 76:1581–1586. 2012. View Article : Google Scholar : PubMed/NCBI
8	Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T, Tsuruta Y, Suzuki H, Uemura S, Takeuchi T, Koike M and Suzuki R: Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology. 96:465–472. 1999. View Article : Google Scholar : PubMed/NCBI
9	Rowley AH, Eckerley CA, Jäck HM, Shulman ST and Baker SC: IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol. 159:5946–5955. 1997.PubMed/NCBI
10	Cui J, Zhou Y, Hu H, Zhao L, Du Z and Du H: PGK1 as an immune target in Kawasaki disease. Clin Exp Immunol. 194:371–379. 2018. View Article : Google Scholar : PubMed/NCBI
11	Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. 2005.
12	Sun S, Ma H, Han G, Wu R, Zou H and Liu Y: Efficient enrichment and identification of phosphopeptides by cerium oxide using on-plate matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Rapid Commun Mass Spectrom. 25:1862–1868. 2011. View Article : Google Scholar : PubMed/NCBI
13	Rucker G and Schumacher M: Summary ROC curve based on a weighted Youden index for selecting an optimal cutpoint in meta-analysis of diagnostic accuracy. Stat Med. 29:3069–3078. 2010. View Article : Google Scholar : PubMed/NCBI
14	Ruan Y, Ye B and Zhao X: Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Pediatr Infect Dis J. 32:e397–e402. 2013. View Article : Google Scholar : PubMed/NCBI
15	Liu R, Gao F, Huo J and Yi Q: Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets. 23:11–16. 2012. View Article : Google Scholar : PubMed/NCBI
16	Iemura M, Ishii M, Sugimura T, Akagi T and Kato H: Long term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function. Heart. 83:307–311. 2000. View Article : Google Scholar : PubMed/NCBI
17	Newburger JW, Takahashi M and Burns JC: Kawasaki disease. J Am Coll Cardiol. 67:1738–1749. 2016. View Article : Google Scholar : PubMed/NCBI
18	Meissner HC and Leung DY: Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J. 19:91–94. 2000. View Article : Google Scholar : PubMed/NCBI
19	Fujieda M, Karasawa R, Takasugi H, Yamamoto M, Kataoka K, Yudoh K, Kato T, Ozaki S and Wakiguchi H: A novel anti-peroxiredoxin autoantibody in patients with Kawasaki disease. Microbiol Immunol. 56:56–61. 2012. View Article : Google Scholar : PubMed/NCBI
20	Matsunaga A, Harita Y, Shibagaki Y, Shimizu N, Shibuya K, Ono H, Kato H, Sekine T, Sakamoto N, Igarashi T and Hattori S: Identification of 4-Trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) as a candidate serum autoantibody target for Kawasaki disease. PLoS One. 10:e01281892015. View Article : Google Scholar : PubMed/NCBI
21	Yamamoto YH, Kimura T, Momohara S, Takeuchi M, Tani T, Kimata Y, Kadokura H and Kohno K: A novel ER J-protein DNAJB12 accelerates ER-associated degradation of membrane proteins including CFTR. Cell Struct Funct. 35:107–116. 2010. View Article : Google Scholar : PubMed/NCBI
22	Sopha P, Kadokura H, Yamamoto YH, Takeuchi M, Saito M, Tsuru A and Kohno K: A novel mammalian ER-located J-protein, DNAJB14, can accelerate ERAD of misfolded membrane proteins. Cell Struct Funct. 37:177–187. 2012. View Article : Google Scholar : PubMed/NCBI
23	Kim CP, Hantouche C, Wong M, Matthes E, Robert R, Hanrahan JW, Shrier A and Young JC: Hsp70 and DNAJA2 limit CFTR levels through degradation. PLoS One. 14:e2209842019.
24	Li K, Jiang Q, Bai X, Yang YF, Ruan MY and Cai SQ: Tetrameric assembly of K⁺ channels requires ER-located chaperone proteins. Mol Cell. 65:52–65. 2017. View Article : Google Scholar : PubMed/NCBI
25	Martin CA, Carsons SE, Kowalewski R, Bernstein D, Valentino M and Santiago-Schwarz F: Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: Possible mechanisms of hsp/DC-mediated cross-priming. J Immunol. 171:5736–5742. 2003. View Article : Google Scholar : PubMed/NCBI
26	Lenzi C, Palazzuoli A, Giordano N, Alegente G, Gonnelli C, Campagna MS, Santucci A, Sozzi M, Papakostas P, Rollo F, et al: H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J Gastroenterol. 12:7815–7820. 2006. View Article : Google Scholar : PubMed/NCBI
27	Li XS, Xu Q, Fu XY and Luo WS: Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer. J Cancer Res Clin Oncol. 140:1305–1313. 2014. View Article : Google Scholar : PubMed/NCBI
28	Rothenbacher D, Hoffmeister A, Bode G, Miller M, Koenig W and Brenner H: Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: A case control study with focus on markers of systemic inflammation and lipids. Atherosclerosis. 156:193–199. 2001. View Article : Google Scholar : PubMed/NCBI
29	Li XS, Xu Q, Fu XY and Luo WS: Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer. J Cancer Res Clin Oncol. 140:1305–1313. 2014. View Article : Google Scholar : PubMed/NCBI
30	Sun J and Zhai S: Development of Kawasaki disease pathogenesis. J App Clin Pediatrics. 22:10372007.
31	Guidelines for diagnosis and management of cardiovascular Sequelae in Kawasaki disease (JCS 2003). J Cardiol. 43:263–283. 2004.(In Japanese). PubMed/NCBI
32	Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q and Yang XQ: Clinical analysis of 942 cases of Kawasaki disease. Zhonghua Er Ke Za Zhi. 44:324–328. 2006.(In Chinese). PubMed/NCBI
33	Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D, Eguchi T, Maruyama I and Kawano Y: Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. Br J Haematol. 148:285–292. 2010. View Article : Google Scholar : PubMed/NCBI